Market revenue in 2023 | USD 251.7 million |
Market revenue in 2030 | USD 445.1 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | System and Technology Support Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.8% in 2023. Horizon Databook has segmented the Asia Pacific clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
The clinical trial imaging market in Asia Pacific is anticipated to exhibit significant growth over the forecast period. This can be attributed to rapid growth of the population and increased R&D activity in this region. In addition, there is high need for traditional and advanced devices & therapies in Asia Pacific.
Moreover, the cost of conducting clinical trials in Asia is lower as compared to Western Europe and the U.S. For instance, the clinical trial cost in China and India is 25% to 40% less than that in Western countries. Asia Pacific has a large population and offers great opportunity to conduct clinical trials.
Asia has become a preferred outsourcing destination due to its huge treatment-naive population, faster process of recruiting patients, cost-effectiveness, developing clinical infrastructure, and highly skilled investigators, resulting in the growth of clinical trial imaging market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific clinical trial imaging market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account